ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2019 American Transplant Congress

    Panniculectomy at the Time of Living Donor Renal Transplantation: An Eight Year Experience

    L. M. Ngaage1, A. Elegbede2, K. K. Tasidina1, S. Gebran3, E. Rada1, A. J. Nam3, J. R. Scalea4, S. Niederhaus4, D. Singh1, J. S. Bromberg4, S. T. Bartlett4, Y. M. Rasko1

    1Department of Plastic Surgery, University of Maryland Medical Center, Baltimore, MD, 2Department of Plastic & Reconstructive Surgery, Johns Hopkins Hospital / University of Maryland Medical Center, Baltimore, MD, 3Division of Plastic & Reconstructive Surgery, R Adams Cowley Shock Trauma Center, Baltimore, MD, 4Department of Transplant Surgery, University of Maryland Medical Center, Baltimore, MD

    *Purpose: Removal of the pannus, or panniculectomy, can be performed as a prophylactic procedure preceding renal transplantation to enable obese patients to meet criteria for…
  • 2019 American Transplant Congress

    A Clinical Analysis for Low-Dose Immunoglobulin United with Plasmapheresis in High Sensitization Renal Transplantation Recipients

    L. Xu1, J. Zhang2

    1Chinese PLA General Hospital Eighth Medical Centre, Beijing, China, 2Nursing Department, Chinese PLA General Hospital, Beijing, China

    *Purpose: To analyze the role of low-dose intravenous immunoglobulin (IVIG) united with plasmapheresis in high sensitization renal transplantation recipients.*Methods: Four patients with high levels of…
  • 2019 American Transplant Congress

    Variations in Recipient and Donor Clinical Characteristics between Kidney Transplant Centers

    W. T. McKinney1, M. Bruin2, S. Chu2, D. Schladt3, J. Snyder3, A. Matas4, B. Kasiske5, A. K. Israni3

    1Nephrology, Hennepin Healthcare Research Institute, Minneapolis, MN, 2College of Design, University of Minnesota, St. Paul, MN, 3Scientific Registry of Transplant Recipients, Hennepin Healthcare Research Institute, Minneapolis, MN, 4Department of Surgery, University of Minnesota, Minneapolis, MN, 5Department of Medicine, Hennepin Healthcare, Minneapolis, MN

    *Purpose: When a patient can choose at which kidney transplant program to establish care, prior knowledge of program acceptance practices (of candidates and donors) can…
  • 2019 American Transplant Congress

    Impact of Everolimus Therapy on HIV Persistence and Gene Expression in Transplant Patients

    A. Zarinsefat1, C. Schreiner1, C. Cameron2, S. Chu1, M. P. Busch1, T. Liegler1, S. G. Deeks1, T. J. Henrich1, P. G. Stock1

    1UC San Francisco, San Francisco, CA, 2Case Western Reserve University, Cleveland, OH

    *Purpose: mTOR is a key regulatory kinase that controls cell-cycle progression. mTOR inhibitors have been shown to reduce expression of CCR5 and promote viral transcriptional…
  • 2019 American Transplant Congress

    Impact of an mHealth, Electronic Pillbox Intervention on Tacrolimus Variability in Kidney Transplantation: Results of a Prospective Randomized Clinical Trial

    J. W. McGillicuddy, L. Sox, J. Chandler, F. Treiber, D. Taber

    Medical University of South Carolina, Charleston, SC

    *Purpose: Medication non-adherence (MNA) is a major risk factor and leading cause of late allograft loss in kidney transplant (KTX) recipients. Tacrolimus trough concentration variability,…
  • 2019 American Transplant Congress

    Blood Profiling Reflects a Significant Down-Regulation in Oxidative Phosphorylation Following Renal Transplantation with DCD and AKI Allografts

    S. Walker1, L. Cox2, C. Langefeld2, B. Freedman2, A. Farney2, J. Rogers2, C. Jay2, R. Stratta2, G. Orlando2

    1Wake Forest Institute for Regenerative Medicine, Winston Salem, NC, 2Wake Forest Baptist Medical Center, Winston Salem, NC

    *Purpose: The human kidney transplant (KT) patient provides a unique and compelling in situ model system to study molecular events that underlie graft recovery following…
  • 2019 American Transplant Congress

    Transplantation of Kidneys from Hepatitis C Infected Donors to Hepatitis C Negative Recipients

    M. Z. Molnar, O. Cseprekal, M. Yazawa, M. Talwar, V. Balaraman, V. Mas, D. Maluf, R. Helmick, L. Campos, N. Nezakatgoo, C. Eymard, P. Horton, R. Verma, A. Jenkins, C. R. Handley, H. Snyder, C. Cummings, U. A. Agbim, B. Maliakkal, S. K. Satapathy, S. P. Nair, J. D. Eason

    Methodist University Hospital Transplant Institute, Memphis, TN

    *Purpose: There are no data on the safety of kidney transplantation from hepatitis C (HCV) NAT positive donors to HCV naïve recipients. We report the…
  • 2019 American Transplant Congress

    Robotic-Assisted versus Open- Kidney Transplantation in Non-Obese Recipients

    P. R. Modi, B. Pal, S. Singla, R. Chauhan, V. Kothari, A. Mishra, M. Modi, B. Butala, V. Kute, H. Patel, V. Trivedi

    Transplantation Surgery and Urology, Institute of Kidney Diseases and Research Centre, Ahmedabad, India

    *Purpose: Robotic Kidney Transplantation (RKT) is emerging modality of treatment for patient with end stage kidney diseases. It is accepted for obese recipients. However, there…
  • 2019 American Transplant Congress

    Eculizumab Deposition in Renal Transplants

    D. WANG1, S. H. Nasr1, A. B. Farris2, C. A. Schinstock3, M. P. Alexander1, L. D. Cornell1

    1Department of Laboratory Medicine and Pathology, Mayo Clinic, Rochester, MN, 2Pathology & Laboratory Medicine, Emory University, Atlanta, GA, 3Division of Nephrology & Hypertension, Department of Internal Medicine, Mayo Clinic, Rochester, MN

    *Purpose: Eculizumab is a recombinant humanized IgG monoclonal antibody that inhibits C5, thereby preventing the activation of C5a and formation of membrane attack complex C5b-C9.…
  • 2019 American Transplant Congress

    Living Donor Conversion Rates as a Quality Measure for Kidney Program Efficiency for Both New Referrals and Existing Listed Candidates

    E. Woodle1, C. Siemers2, B. Woodle3, C. King2, R. Alloway1, S. Tremblay1

    1U of Cincinnati, Cincinnati, OH, 2UC Health, Cincinnati, OH, 3U of Arkansas, Little Rock, AR

    *Purpose: Arguably the most important achievement for renal failure patients is identification of a living donor (LD)and transplantation with a LD kidney. Given these considerations…
  • « Previous Page
  • 1
  • …
  • 213
  • 214
  • 215
  • 216
  • 217
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2026 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences